(19)
(11) EP 4 577 207 A1

(12)

(43) Date of publication:
02.07.2025 Bulletin 2025/27

(21) Application number: 23757303.5

(22) Date of filing: 22.08.2023
(51) International Patent Classification (IPC): 
A61K 31/397(2006.01)
A61P 9/00(2006.01)
 A61K 31/506(2006.01)
A61K 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/397; A61K 31/506; A61P 9/00; A61K 9/2054; A61K 9/2027
 
C-Sets:
  1. A61K 31/397, A61K 2300/00;
  2. A61K 31/506, A61K 2300/00;
(86) International application number:
PCT/EP2023/073000
(87) International publication number:
WO 2024/042061 (29.02.2024 Gazette 2024/09)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.08.2022 US 202263399755 P
19.09.2022 WO PCT/EP2022/075957
07.02.2023 US 202363483574 P
10.05.2023 US 202363501313 P

(71) Applicant: NewAmsterdam Pharma B.V.
1411 DC Naarden (NL)

(72) Inventors:
  • CRAIG, Joanne Lesley
    1411 DC Naarden (NL)
  • CUI, Sheng
    1411 DC Naarden (NL)
  • DAVIDSON, Michael Harvey
    1411 DC Naarden (NL)
  • DITMARSCH, Marc
    1411 DC Naarden (NL)
  • KASTELEIN, Johannes Jacob Pieter
    1411 DC Naarden (NL)
  • SMOLENSKAYA, Valeriya Nikolayevna
    Lafayette, IN 47905 (US)
  • RĂ–THELI, Andreas RenĂ©
    Thousand Oaks 91320-1799 (US)
  • KISHIDA, Muneki
    1411 DC Naarden (NL)
  • BORTHS, Christopher J.
    Thousand Oaks 91320-1799 (US)

(74) Representative: Nederlandsch Octrooibureau 
P.O. Box 29720
2502 LS The Hague
2502 LS The Hague (NL)

   


(54) OBICETRAPIB AND EZETIMIBE COMBINATION TREATMENT AND FIXED DOSE PHARMACEUTICAL COMPOSITIONS